The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases

Author： Travaglione Sara   Loizzo Stefano   Ballan Giulia   Fiorentini Carla   Fabbri Alessia  

Publisher： MDPI

E-ISSN： 2072-6651|6|1|270-282

ISSN： 2072-6651

Source： Toxins, Vol.6, Iss.1, 2014-01, pp. : 270-282

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases

By Cao Dan-Dan   Li Lu   Chan Wai-Yee  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-05 ,pp. : 842-842

MDPI

Access to resources Recommend Favorite

Is Ghrelin Synthesized in the Central Nervous System?

By Cabral Agustina   López Soto Eduardo J.   Epelbaum Jacques   Perelló Mario  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 638-638

MDPI

Access to resources Recommend Favorite

High Affinity Binding of Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1) to Lu/BCAM Adhesion Glycoprotein

By Reppin Franziska   Cochet Sylvie   El Nemer Wassim   Fritz Günter   Schmidt Gudula  

Toxins, Vol. 10, Iss. 1, 2017-12 ,pp. : 3-3

MDPI

Access to resources Recommend Favorite

Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1): Toxin Biology, in Vivo Applications and Therapeutic Potential

By Fabbri Alessia   Travaglione Sara   Fiorentini Carla  

Toxins, Vol. 2, Iss. 2, 2010-02 ,pp. : 283-296

MDPI

Access to resources Recommend Favorite

Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?

By Martínez-Moreno Carlos G.   Calderón-Vallejo Denisse   Harvey Steve   Arámburo Carlos   Quintanar José Luis  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 375-375

MDPI

Access to resources Recommend Favorite